Jump to content

Danny Deck

Members
  • Posts

    238
  • Joined

  • Last visited

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

Danny Deck's Achievements

State Champion

State Champion (8/14)

  • Very Popular
  • Conversation Starter
  • One Year In
  • Collaborator
  • Dedicated

Recent Badges

108

Reputation

  1. What features of the CSR do you use? If you aren't using the lounge perk at all, a downgrade to the Sapphire Preferred might be in order. You keep the really good travel insurance perks (primary car rental insurance, etc) and ability to transfer to partners for a much more reasonable annual fee. The easiest premium travel card to get your annual fee back on, or justify to yourself anyway, is the Capital One Venture X which has a $395 annual fee offset by a $300 credit for travel booked through their portal and a 10,000 point anniversary bonus. Transfer partners domestically are not nearly as good as Chase though. If you live next to a hub for an airline, you might consider the premium card offering for that airline. Oh and last, my BIL gets in just under the line on the annual fee increase for the CSR. If you do as well, you can check out which of the new coupons you can actually use and decide for sure next year.
  2. Ray Miller is from Oklahoma, so I'm voting for him.
  3. Have you checked out the web address of this event? https://nationaldualsinvitational.com/
  4. Haven't listened to this episode yet, but here's an example of all of the things GLP1s have shown promise for. I know there can be significant weight rebound if you go off Ozempic, but I wonder about it's use in some of these others. Like if you use it to abstain from recreational drug use for a year, will you be able to stay off those if you go off a GLP1? Certainly it seems to me like the effect could be more durable since cocaine is more optional than food.
  5. As with weight loss from just diet, I think you have to be careful that you maintain muscle mass and I wouldn't be surprised about bone density as well. A quick search found this: The researchers found that people who took a GLP-1 receptor agonist had reduced hip and spine bone mineral density when they didn’t exercise, compared to people who took a placebo or just exercised. “These findings suggest that the addition of exercise to GLP-1 RA treatment is an effective weight loss strategy while preserving bone health,” the researchers wrote. Study: Weight Loss Drugs Like Ozempic Could Trigger Bone Loss Resistance training is super important.
  6. You asked about a raw number, that's what I went looking for. I'm not usually trying to cherry pick for my advantage, I'm trying to better understand a situation. Next time I will try to predict what you want not just what you say.
  7. Several other GLP1s have been approved for weight loss. I was using Ozempic as a stand in for the class of drugs as the most well known. The initial studies for other behaviors have been very positive and fascinating.
  8. I didn't say anything was. But you should use all the tools in the toolbox. Ozempic has shown strong benefits far beyond just weight control and helps people have healthy lifestyles.
  9. The time period was the previous administration. It looks like there were lots of arrests happening before. I would imagine 2024 data is not complete on this chart.
  10. 4/5 were arrested under the previous administration and 2 by local law enforcement. I imagine being part of an international gang with operations in a number of states aids your ability to avoid capture.
  11. Of the 6 in the video, it looks like 1 was arrested in Aurora in September by Aurora PD, 2 by DHS in NYC in November, 1 in Aurora in December by Aurora PD, and now this guy in NYC by DHS. 1 remains at large.
  12. Aren't the incentives bad? High performing employees with options choose to leave and low performing employees without options choose to stay?
  13. https://www.independent.co.uk/news/world/americas/us-politics/karoline-leavitt-condoms-gaza-doge-b2688322.html
×
×
  • Create New...